Have a feature idea you'd love to see implemented?
Let us know!
XTNT Xtant Medical Holdings Inc
Price (delayed)
$0.4147
Market cap
$57.65M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.13
Enterprise value
$86.51M
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal
Highlights
The company's gross profit rose by 49% YoY
The revenue is up by 45% year-on-year and by 2.6% since the previous quarter
XTNT's debt has surged by 56% year-on-year and by 2.7% since the previous quarter
Xtant Medical Holdings's quick ratio has decreased by 35% YoY and by 13% from the previous quarter
Key stats
What are the main financial stats of XTNT
Market
Valuations
Earnings
Shares outstanding
139.01M
Market cap
$57.65M
Enterprise value
$86.51M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.76
Revenue
$113.86M
EBIT
-$13M
EBITDA
-$8.91M
Free cash flow
-$16.9M
Per share
Balance sheet
Liquidity
EPS
-$0.13
Free cash flow per share
-$0.13
Book value per share
$0.35
Revenue per share
$0.84
TBVPS
$0.61
Total assets
$98.88M
Total liabilities
$53.16M
Debt
$35.95M
Equity
$45.73M
Working capital
$37.74M
Debt to equity
0.79
Current ratio
2.12
Quick ratio
0.82
Net debt/EBITDA
-3.24
Margins
Efficiency
Dividend
EBITDA margin
-7.8%
Gross margin
60.9%
Net margin
-15.4%
Operating margin
-12.3%
Return on assets
-18.5%
Return on equity
-37.1%
Return on invested capital
-17.3%
Return on capital employed
-19.9%
Return on sales
-11.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XTNT stock price
How has the Xtant Medical Holdings stock price performed over time
Intraday
0.66%
1 week
-7.62%
1 month
-24.6%
1 year
-65.15%
YTD
-63.3%
QTD
-38.65%
Financial performance
How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$113.86M
Gross profit
$69.33M
Operating income
-$14M
Net income
-$17.59M
Gross margin
60.9%
Net margin
-15.4%
XTNT's operating income has dropped by 73% year-on-year and by 2.9% since the previous quarter
The company's gross profit rose by 49% YoY
The revenue is up by 45% year-on-year and by 2.6% since the previous quarter
Xtant Medical Holdings's operating margin has decreased by 19% YoY
Growth
What is Xtant Medical Holdings's growth rate over time
Valuation
What is Xtant Medical Holdings stock price valuation
P/E
N/A
P/B
1.18
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.76
XTNT's P/B is 58% below its 5-year quarterly average of 2.8 and 53% below its last 4 quarters average of 2.5
The equity has contracted by 16% YoY
The stock's price to sales (P/S) is 59% less than its 5-year quarterly average of 1.2 and 55% less than its last 4 quarters average of 1.1
The revenue is up by 45% year-on-year and by 2.6% since the previous quarter
Efficiency
How efficient is Xtant Medical Holdings business performance
Dividends
What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XTNT.
Financial health
How did Xtant Medical Holdings financials performed over time
The total assets is 86% more than the total liabilities
Xtant Medical Holdings's total liabilities has increased by 42% YoY and by 5% from the previous quarter
Xtant Medical Holdings's quick ratio has decreased by 35% YoY and by 13% from the previous quarter
XTNT's debt is 21% smaller than its equity
The debt to equity has soared by 88% YoY
XTNT's debt has surged by 56% year-on-year and by 2.7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.